| Name | Title | Contact Details |
|---|
Korman Healthcare is a Chandler, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1995, MIE has developed the WebChart EHR portfolio, a minimally invasive EHR which operates on any web browser or mobile device, including iPads or Smartphones.
Pontotoc Technology Center (PTC) has a diverse economy with a large health community including Mercy Hospital, Chickasaw Nation Health System and Rolling Hills Psychiatric Hospital. Pontotoc also has a large mining sector with Holcim, Unimin, and Fairmount Minerals, a large manufacturing sector with Flex-N-Gate and Solo Cup and a large service industry with Pre Paid Legal Services dba Legal Shield and Interactive Response Technologies. These diverse sectors are served in a rural setting.
Today, with literally thousands of sports apps, medical apps, nutritional apps and of course doctors` offices and hospitals offering online access to your medical records the chances of anyone checking all their vitals, nutritional intake etc. is close to nil… Why? Way too much data!! WoMBA takes all your data sources and aggregates it under one platform. Aggregated data allows you to see a full picture of your health and gives you a full profile of your E-DNA. Not only does utilizing WoMBA give you easy access to your collected data but many insurance companies will give you a discount for using services such as WoMBA and last but not list, if not the most important, WoMBA can save your life.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.